- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Yousaf is a consultant medical oncologist with both an NHS and private practice at The Royal Marsden Hospital. She is a specialist in the treatment of lung cancer, mesothelioma and thymoma using systemic anticancer therapies which includes immunotherapy, chemotherapy and targeted therapies.
Dr Yousaf qualified from the University of Newcastle upon Tyne in 2002. She completed her medical oncology training at The Royal Marsden Hospital and was appointed as a consultant at the Royal Marsden in 2016. She also completed a period of research leading to the award of an MD(res) at the University of Leicester where her area of interest was using digital technologies to monitor patients.
Dr Yousaf was appointed Honorary Faculty at the Insitute of Cancer research in 2020. She has authored multiple peer-reviewed publications and undertakes a variety of clinical research. She has also served as a clinical expert for NICE.
Dr Yousaf has also been awarded an MBA after a period of study at London Business School. She set up the Royal Marsden Hospital Acute Oncology Service and the Royal Marsden Hospital and Royal Brompton Hospital Thoracic Cancer service. She remains clinical lead for the Thoracic Cancer service.
In addition, she continues to pursue her interest in Digital Health as The Chief Clinical Information Officer.
Areas of interest
non-small cell lung cancer; small cell lung cancer; large cell neuroendocrine lung cancer; oncogene addicted lung cancer; lung cancer in people with a smoking history; lung cancer in people who have never smoked; mesothelioma; thymoma, adult patients; immunotherapy; targeted therapies; personalised medicine; chemotherapy
Medical secretaries
- Kasey Hendrixson
- The Royal Marsden Fulham road London SW3 6JJ
- 020 7811 8921
- pp.yousaf@rmh.nhs.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)